(Q35528770)

8 August 2017

title

Efficacy of loxapine in the treatment of paranoid schizophrenia (English)

1 reference

8 August 2017

1 reference

1 reference

15 October 2022

author name string

M. P. Bishop

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14350

8 October 2022

G. M. Simpson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14350

8 October 2022

C. W. Dunnett

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14350

8 October 2022

H. Kiltie

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14350

8 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14350

8 October 2022

publication date

1 January 1977

1 reference

8 August 2017

31 January 1977

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14350

8 October 2022

number of pages

9

1 reference

full work available at URL

inferred from page(s)

http://link.springer.com/content/pdf/10.1007/BF00431725.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF00431725/fulltext.html

15 October 2022

1 reference

http://link.springer.com/content/pdf/10.1007/BF00431725

15 October 2022

1 reference

15 October 2022

1 reference

8 August 2017

volume

51

1 reference

8 August 2017

issue

2

1 reference

8 August 2017

page(s)

107-115

1 reference

Treatment of schizophrenic reactions with phenothiazine derivatives. A comparative study of chlorpromazine, triflupromazine, mepazine, prochlorperazine, perphenazine, and phenobarbital

8 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00431725

Specific therapeutic actions of acetophenazine, perphenazine, and benzquinamide in newly admitted schizophrenic patients

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00431725

Prediction of Improvement in Schizophrenia Under Four Phenothiazines

21 January 2018

1 reference

12 December 2020

Specific indications for different classes of phenothiazines

1 reference

12 December 2020

PHENOTHIAZINE TREATMENT IN ACUTE SCHIZOPHRENIA; EFFECTIVENESS: THE NATIONAL INSTITUTE OF MENTAL HEALTH PSYCHOPHARMACOLOGY SERVICE CENTER COLLABORATIVE STUDY GROUP

1 reference

12 December 2020

The right drug for the right patient

1 reference

12 December 2020

Predicting response to phenothiazines: the right drug for the right patient

1 reference

12 December 2020

Prediction of response to phenothiazines in schizophrenia. A crossvalidation study

1 reference

12 December 2020

TRIFLUPERIDOL IN "PARANOID" AND "NON-PARANOID" SCHIZOPHRENICS

1 reference

12 December 2020

NOSIE-30: A Treatment-Sensitive Ward Behavior Scale

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00431725

1 reference

8 August 2017

1 reference